Carl N. Kraus

Insider Reports History

Entity
Individual
Location
C/O Aceragen, Inc., 15 Tw Alexander Drive, Durham, NC
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl N. Kraus:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Medical Officer Common Stock 252K $863K $3.43 Aug 9, 2024 Direct
Aquestive Therapeutics, Inc. Chief Medical Officer Non-Qualified Stock Option (right to buy) 56.3K Mar 7, 2024 Direct
Aceragen, Inc. CHIEF MEDICAL OFFICER Stock Options (Right ot Buy) 25.4K Jan 20, 2023 Direct

Insider Reports Filed by Carl N. Kraus

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Aug 9, 2024 1 -$37.1K 4 Aug 12, 2024 Chief Medical Officer
AQST Aquestive Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 Chief Medical Officer
AQST Aquestive Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 Chief Medical Officer
AQST Aquestive Therapeutics, Inc. Jun 26, 2023 0 $0 3 Jun 30, 2023 CHIEF MEDICAL OFFICER
ACGN Aceragen, Inc. Jan 20, 2023 1 $0 4 Feb 2, 2023 CHIEF MEDICAL OFFICER
ACGN Aceragen, Inc. Jan 17, 2023 1 $0 4 Jan 19, 2023 Chief Medical Officer
IDRA IDERA PHARMACEUTICALS, INC. Sep 28, 2022 3 $0 4 Sep 30, 2022 Chief Medical Officer
IDRA IDERA PHARMACEUTICALS, INC. Sep 28, 2022 0 $0 3 Sep 30, 2022 Chief Medical Officer